Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain

European Journal of Pharmacology

Volumn 351, Issue 1, 1998, Pages 31-37

  Maj, Jerzy ^a   Dziedzicka Wasylewska, Marta ^a   Rogoz, Renata ^a   Rogóz, Zofia ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

( ) 7 OH DPAT (7 hydroxy dipropylaminotetralin); (Rat); Antidepressant drug; Dopamine D3 receptor autoradiography; Hyperlocomotion

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IMIPRAMINE; MIANSERIN; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; CONTROLLED STUDY; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ADMINISTRATION, ORAL; AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; BRAIN; CITALOPRAM; DOPAMINE AGONISTS; IMIPRAMINE; INJECTIONS, SUBCUTANEOUS; MALE; MIANSERIN; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TETRAHYDRONAPHTHALENES;

EID: 0032511178     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00297-0     Document Type: Article

References (36)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat. Eur. J. Pharmacol. 260, 177-181.
2. 2 receptor mRNA. Brain Res. 564, 203-219.
3. 3-preferring dopamine agonist. Neurosci. Lett. 196, 97-100.
4. 2 receptors in chronic fluoxetine-treated rats. Eur. J. Pharmacol. 322, 123-127.
5. 2-like' agonists. Neuropharmacology 32, 509-510.
6. Damsma, G., Bottema, T., Westerink, B.H.C., Tepper, P.G., Dijkstra, D., Pugsley, T.A., MacKenzie, R.G., Heffner, T.G., Wikström, H., 1993. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur. J. Pharmacol. 249, R9-R10.
7. 2 dopamine receptors in the rat brain. J. Neural Transm. 104, 515-524.
8. Ebert, D., Lammers, C.-H., 1997. Das zentralle dopamine sytem und die depression. Nervenarzt 68, 545-555.
9. 3 autoreceptor-mediated effects. Pharmacol. Biochem. Behav. 52, 275-280.
10. Heron, D.S., Shinitzky, M., Samuel, D., 1980. Lipid fluidity markedly modulates binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. U.S.A. 77, 7453-7467.
11. 3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography. Eur. J. Pharmacol. 261, 179-183.
12. 3-preferring agonist 7-OH-DPAT on motor behavior and place conditioning. Psychopharmacology 122, 351-357.
13. 3-preferring agonists 7-OH-DPAT and PD-128, 907 on motor behaviors and place conditioning. Behav. Pharmacol. 8, 65-74.
14. 2 receptors. J. Pharm. Pharmacol. 41, 555-558.
15. 2 receptor binding before and after treatment of major depression measured by single photon emission computed tomography. Pharmacopsychiatry 30, 189.
16. 3 dopamine receptors. Cell. Mol. Neurobiol. 14, 185-191.
17. 3 receptor agonists, 7-OH-DPAT and quinpirole, on yawning, stereotypy and body temperature in rats. Pharmacol. Biochem. Behav. 52, 503-508.
18. Lammers, C.H., Diaz, G., Levesque, D., Griffon, N., Schwartz, J.C., Sokoloff, P., 1995. Regulation of dopamine receptor mRNA by antidepressants. Pharmacopsychiatry 28, 159.
19. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Pharmacol. 5, 145-153.
20. 3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264, 991-1001.
21. 3H] hydroxy-N,N-di-N-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89, 8155-8159.
22. Maj, J., Wȩdzony, K., 1988. The influence of oxaprotiline enantiomers given repeatedly on the behavioral effects of D-amphetamine and dopamine injected into the nucleus accumbens. Eur. J. Pharmacol. 145, 97-103.
23. Maj, J., Rogóż, Z., Skuza, G., Sowińska, H., 1984. Repeated treatment with antidepressant drugs increases the behavioral response to apomorphine. J. Neural Transm. 60, 273-282.
24. Maj, J., Wȩdzony, K., Klimek, V., 1987. Desipramine given repeatedly enhances behavioral effects of dopamine and D-amphetamine injected into the nucleus accumbens. Eur. J. Pharmacol. 140, 179-185.
25. 2 agonists. J. Neural. Transm. 76, 29-38.
26. 2 agonists. J. Neural Transm. 78, 1-8.
27. 2 receptors in the rat brain. Eur. J. Pharmacol. 304, 49-54.
28. Martin-Iverson, M.T., Leclere, J.F., Fibiger, H.C., 1983. Cholinergic-dopaminergic interactions and the mechanism of action of antidepressants. Eur. J. Pharmacol 94, 193-201.
29. Meyer, M.E., 1996. Mesolimbic 7-OH-DPAT affects locomotor activities in rats. Pharmacol. Biochem. Behav. 55, 209-214.
30. Nocoń, H., Melzacka, M., 1991. Effect of some cationic amphiphilic drugs on phospholipid methylation in the central nervous system of rats. J. Pharm. Pharmacol. 43, 107-110.
31. Paxinos, G., Watson, C., 1986. The Rat Brain Stereotaxic Coordinates. Academic Press, Sydney.
32. Płaźnik, A., Kostowski, W., 1987. The effects of antidepressants and electroconvulsive shock on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur. J. Pharmacol. 135, 389-396.
33. 3) as a target for neuroleptics. Nature 347, 146-151.
34. 2 receptor. Eur. J. Pharmacol. 225, 331-337.
35. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. Gen. Sect. 95, 71-74.
36. Wesemann, W., Melzacka, M., Lausch, R.O., Weiner, N., Mennel, H.D., Sontag, K.H., 1988. Age and drug-dependent changes of serotonin binding sites and membrane architecture. Abstr. XVIth C.I.N.P. Congress Psychopharmacol., Vol. 96, Suppl., pp. 165.